Quick Intro

ReSurfX is an outcomes intelligence technology company improving innovation and ROI from data-intensive activities of enterprises to enhance insights, automate knowledge extraction, and predict outcome directions in advance - with primary focus on the health sector. At the forefront of innovation in outcomes intelligence, ReSurfX harnesses cutting-edge AI to transform data into actionable insights. Our novel data-source agnostic Adaptive Hypersurface Technology (AHT) approach enables exceptionally accurate predictions and unparalleled insights, setting a new standard for outcomes intelligence. Our AI solutions, such as Advance Outcomes Alert System (AOAS) deliver these value with superior accuracy, robustness, and novel insights.

ReSurfX's focus is on reliable AI solutions to drive value and innovation. Our cloud-native enterprise outcomes intelligence product ReSurfX::vysen is the market leader in accuracy, delivering best-in-class functionalities at scale. Our powerful System Response-based Triggers and Outcomes Predictor, SyRTOP offers demonstrated prediction power and highly accurate novel insights is a core component of AOAS.

In the health sector we deliver highly reliable end-to-end solutions for Pharma and Biotech enterprises, healthcare delivery organizations (e.g., hospitals and payors), and other stakeholders. By improving outcomes across all stages of development (discovery - clinical trial - sale of high-cost products) and medical care, we enable effective treatment choices and patient care with quantitative and AI-based evidence.

AHT improves output from other tools used in AI. By combining AHT with other AI tools and technologies, we create robust, accurate, innovative, and novel outcome intelligence solution ensembles that deliver unprecedented results. We leverage the recent improvements in generative AI and agentic infrastructure for ease of data transformations and to decipher novel value provided by our outcomes intelligence AI solutions.

This page gives a quick outline about us. You can find detailed information from navigation bar of this website and may links therein.

Rapid fire introduction video.

ReSurfX::vysen - SyrTOP AI solution has direct validation supporting use in prospective prediction of outcomes in healthcare settings. Check out: ReSurfX in 2021 – Best-in-class Outcome Predictors, Innovation Catalysts and ROI Multipliers for an example of prediction insights on drug-drug-interactions that have been flagged by FDA guidance related to co-prescribing based on real-life post-market surveillance (PMS) data.

Our focus is on end-to-end solutions for Pharma and Biotech enterprises and healthcare sector (spanning discovery - clinical trial - high cost product sale and medical care with quantitative evidence). ReSurfX uses proprietary IP supporting our solutions and also has many issued patents. ReSurfX is also leveraging AHT in powerful Adaptive Operating Point Solutions (AOPS), a suite of analytics and prediction functionalities built for environments with lesser compute resources such as at the edges (including smartphones) for use in tailored end-use solutions for rapid, sensitive and accurate decisions with the adaptiveness and personalization that are inherent to AHT.

Below are quick outlines of our" propositions and market value" and "product and validations"

The former is a version used in CIO Review magazine when we were recognized as 20 Most Promising Analytics Vendors.

*please refresh page if BOTH the following pdf documents do not auto-load